Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satdarshan P Monga

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Biorxiv : the Preprint Server for Biology|November 1, 2024
NOTCH1 drives tumor plasticity and metastasis in hepatocellular carcinomaKatherine E Lindblad, Romain Donne, Ian Liebling, et al.
The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.
The American Journal of Pathology|February 23, 2019
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma PathogenesisQian Min, Laura Molina, Jing Li, et al.
Elife|October 5, 2021
β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reactionShikai Hu, Jacquelyn O Russell, Silvia Liu, et al.
Hepatology Communications|January 4, 2022
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular CarcinomaYang Xie, Runzi Sun, Li Gao, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Cancer Research Communications|April 28, 2025
Inferring Drug-Gene Relationships in Cancer Using Literature-Augmented Large Language ModelsYing-Ju Lai, Li-Ju Wang, Tyler M Yasaka, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Development of mutated β-catenin gene signature to identify <i>CTNNB1</i> mutations from whole and spatial transcriptomic data in patients with HCCBrandon M Lehrich, Junyan Tao, Silvia Liu, et al.
Molecular Cancer Therapeutics|July 9, 2016
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginShanthi Ganesh, Martin L Koser, Wendy A Cyr, et al.
Nature Chemical Biology|January 26, 2021
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistanceYuan Liu, Michael J Jurczak, Travis B Lear, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|November 1, 2024
NOTCH1 drives tumor plasticity and metastasis in hepatocellular carcinomaKatherine E Lindblad, Romain Donne, Ian Liebling, et al.
The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.
The American Journal of Pathology|February 23, 2019
β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma PathogenesisQian Min, Laura Molina, Jing Li, et al.
Elife|October 5, 2021
β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reactionShikai Hu, Jacquelyn O Russell, Silvia Liu, et al.
Hepatology Communications|January 4, 2022
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular CarcinomaYang Xie, Runzi Sun, Li Gao, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Cancer Research Communications|April 28, 2025
Inferring Drug-Gene Relationships in Cancer Using Literature-Augmented Large Language ModelsYing-Ju Lai, Li-Ju Wang, Tyler M Yasaka, et al.
JHEP Reports : Innovation in Hepatology|November 25, 2024
Development of mutated β-catenin gene signature to identify <i>CTNNB1</i> mutations from whole and spatial transcriptomic data in patients with HCCBrandon M Lehrich, Junyan Tao, Silvia Liu, et al.
Molecular Cancer Therapeutics|July 9, 2016
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginShanthi Ganesh, Martin L Koser, Wendy A Cyr, et al.
Nature Chemical Biology|January 26, 2021
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistanceYuan Liu, Michael J Jurczak, Travis B Lear, et al.
Pageof 15